Munich - Start of a new trial site (TUM)

Today the 15th of June 2026, the Univeristy Hospital Munich (TUM)  became officially another active trial site of the STOP-PKD Study.

The team of Prof. Lutz Renders cares for patients with a wide range of nephrological issues, including those affected by autosomal dominant polycystic kidney disease (ADPKD).

Interested patients can now make an appointment at the trial site in Munich to obtain detailed information about the trail and potential participation.

Telefon: +49 089 4140 5351

E-Mail: sabine.engelhardt@mri.tum.de